← back to search

Gabriel Chamie

University of California, San Francisco · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, HIV Research and Treatment, and Adolescent Sexual and Reproductive Health.
h-index
38
citations
4,971
works
195
NIH funding
primary concept
email

Recent publications

Community health worker–facilitated telehealth for moderate–severe hypertension care in Kenya and Uganda: A randomized controlled trial
PLoS Medicine 2025cited by 9position: middledoi
Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension
The Lancet HIV 2024cited by 36position: middledoi
A community‐based dynamic choice model for HIV prevention improves PrEP and PEP coverage in rural Uganda and Kenya: a cluster randomized trial
Journal of the International AIDS Society 2023cited by 28position: middledoi
Dynamic choice HIV prevention intervention at outpatient departments in rural Kenya and Uganda
AIDS 2023cited by 20position: middledoi
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial
The Lancet Global Health 2023cited by 11position: firstdoi
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods
JAMA Network Open 2022cited by 45position: middledoi
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Science Translational Medicine 2021cited by 235position: middledoi
Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta‐analysis
Alcoholism Clinical and Experimental Research 2021cited by 80position: middledoi
HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda
PLoS Medicine 2021cited by 74position: middledoi
HIV testing approaches to reach the first UNAIDS 95% target in sub-Saharan Africa
The Lancet HIV 2021cited by 66position: firstdoi
Dimensions of HIV-related stigma in rural communities in Kenya and Uganda at the start of a large HIV ‘test and treat’ trial
PLoS ONE 2021cited by 60position: middledoi
Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco
Clinical Infectious Diseases 2021cited by 45position: middledoi
Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials
Biostatistics 2021cited by 44position: middledoi
Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda
Journal of the International AIDS Society 2021cited by 36position: middledoi
Post-traumatic stress disorder among persons with HIV who engage in heavy alcohol consumption in southwestern Uganda
BMC Psychiatry 2021cited by 27position: middledoi
The Drinkers’ Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial
Trials 2021cited by 16position: lastdoi
Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco
The Journal of Infectious Diseases 2020cited by 166position: middledoi
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study
The Lancet HIV 2020cited by 161position: middledoi
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
Journal of the International AIDS Society 2020cited by 152position: middledoi
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco
Clinical Infectious Diseases 2020cited by 104position: firstdoi
Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
Clinical Infectious Diseases 2020cited by 101position: middledoi
Evaluation of a novel community-based COVID-19 ‘Test-to-Care’ model for low-income populations
PLoS ONE 2020cited by 69position: middledoi
The age-specific burden and household and school-based predictors of child and adolescent tuberculosis infection in rural Uganda
PLoS ONE 2020cited by 16position: middledoi
HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa
New England Journal of Medicine 2019cited by 223position: middledoi
Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study
BMC Public Health 2019cited by 119position: middledoi
Machine Learning to Identify Persons at High-Risk of Human Immunodeficiency Virus Acquisition in Rural Kenya and Uganda
Clinical Infectious Diseases 2019cited by 80position: middledoi
Financial incentives for achieving and maintaining viral suppression among HIV-positive adults in Uganda: a randomised controlled trial
The Lancet HIV 2019cited by 53position: lastdoi
Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa
AIDS 2019cited by 43position: lastdoi
Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa
JAMA 2017cited by 135position: middledoi
Gaps in the child tuberculosis care cascade in 32 rural communities in Uganda and Kenya
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2017cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Diane V. Havlir · Global Solutions for Infectious Diseases29 papers (2012–2025)Moses R. Kamya · Universidad Católica de Santa Fe27 papers (2012–2025)Maya L. Petersen · Berkeley College17 papers (2012–2023)Edwin D. Charlebois · Prevention Group17 papers (2012–2021)Dalsone Kwarisiima · Infectious Diseases Research Collaboration17 papers (2012–2021)Jane Kabami · Kabale University16 papers (2012–2025)Tamara D. Clark · University of California, San Francisco16 papers (2012–2021)Laura B. Balzer · Berkeley Public Health Division15 papers (2014–2025)James Ayieko · Kenya Medical Research Institute12 papers (2016–2025)Elizabeth A. Bukusi · University of California, San Francisco11 papers (2016–2023)Maya Petersen · University of California, Berkeley10 papers (2016–2025)Harsha Thirumurthy · Indiana University School of Medicine10 papers (2012–2023)Craig R. Cohen · University of California, San Francisco9 papers (2016–2021)Vivek Jain · San Francisco General Hospital8 papers (2012–2022) · 8 papers (2016–2025)Florence Mwangwa · Infectious Diseases Research Collaboration7 papers (2016–2021)Carina Marquez · University of California, San Francisco7 papers (2014–2022)Douglas Black · University of California, Los Angeles6 papers (2014–2022)Asiphas Owaraganise · Infectious Diseases Research Collaboration5 papers (2016–2025) · 5 papers (2016–2021)